Prior to joining Singular Genomics, Daly was CEO at cancer screening company Thrive Earlier Detection, which was acquired by Exact Sciences Corporation for $2.15 billion earlier this year.
Daly’s appointment to the board took effect on Nov. 10, according to the report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
